SNOMED CT Editorial Advisory Group

Page tree

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 5 Next »

Date

01/20/2017

1600-2200 UTC 

 

GoToMeeting Details

https://global.gotomeeting.com/join/374912925

 Use your microphone and speakers (VoIP) - a headset is recommended. Or, call in using your telephone.

Dial +1 (872) 240-3212
Access Code: 374-912-925
Audio PIN: Shown after joining the meeting

Meeting ID: 374-912-925

Attendees

Chair:

AG Members

 

 

 

 

Observers:

 

Apologies

Meeting Files

PDF

Meeting minutes

 

 

 

Objectives

  • Obtain consensus on agenda items

Discussion items

Item
Description
Owner
Notes
Action
1Call to order and role callJCA 

 

2Conflicts of interestJCA  
3Approval of minutes from WellingtonJCA 
  • Approve minutes from Wellington


   Use of Arabic or Roman numerals in FSNs 
   Care plans

 

6Extension of Cauastive agent to include ProductJCA/TMO

There are specific use cases that more appropriately require the use of concepts from the Product hierarchy. The current approach has been to create matching Substances to allow for sufficient modeling, but in many cases this does not make sense and creates duplicate meanings.

E.g. Adverse reaction to product; Allergy to food product, etc.

  • Request Technical services to extend the range of this attribute
8ECE UpdateBGO

Update on ongoing issues with ECE

  • Model for complications and sequela incl. postoperative complications
  • Final approval on editorial guide updates for combined disorders
    • Result of combine disorder naming exercise
  • Updates to allergy models
    • Allergy to substance
    • Allergic disorder caused by substance
    • Pseudoallergy to substance
    • Intolerance to substance
    • SNOMED allergy content and ICD-11
  • Final agreement on the model for surgical complications/sequellae
  • Editorial guidance for combined disorders (BGO)
9Clinical genomicsEAG

Editorial principles to support content development of clinical genomics content.

The purpose of this discussion is to develop the high level issues that need to be addressed regarding clinical genomics including scope, alignment with external standards, sources of truth, level of granularity, etc.

 
10Aligning SNOMED CT with clinical use casesKCA/JCAHigh level discussion on whether SNOMED CT is appropriately organized to support the highly variable granularity of content the are influenced by current EHR applications (i.e. single code recording of pre-coordinated content) and newer initiatives that are focused on capturing more structured data (e.g. CIMI, FHIR) 
11Unilateral findings and proceduresJCA

Revisit of this issue following decision on laterality. From the discussion held in Uruguay:

  • The Unilateral concepts were confusing both from a clinical usage and terminological aspect.
  • Having these concepts located in the Situation with explicit context hierarchy while lateralized concepts are was not helpful, he said. User feedback showed confusion.
  • In the short term it was suggested that we remove them from the situation hierarchy, providing a clear message to users, and eventually getting rid of them.

In light of the approval of lateralized content into the International release, is there a compelling reason to keep these concepts (approx. 325).

14Organizational groupersJCA

The IHTSDO Editorial Panel would like guidance on the creation of a policy regarding the addition of fully defined "grouper" concepts that are not clinically useful, but are used primarily for navigation of the hierarchy. For example "Procedure on vena cava" without any specifics as to the nature of the procedure.

 
15Action item reviewEAG

Space Actions

 
16Meeting schedule 2017EAG